Preprint / Version 1

Exploring the Pathophysiology of Migraine with Aura

##article.authors##

  • June Choi Johns Creek High School

DOI:

https://doi.org/10.58445/rars.1101

Keywords:

Pathophysiology, Migraine, Aura

Abstract

A migraine is a common neurological disease that causes a headache with the symptoms of severe throbbing or pulsing pain, typically on one side of the head. Up to 30% of people with migraine experience auras or visual disturbances as a symptom that occurs before or during the headache. Through experiments using animal models, researchers have found many possible reasons for the cause of migraine. While the underlying mechanisms of this disease are not yet fully understood, current research theorizes that migraine with aura is likely due to Cortical Spreading Depression (CSD). CSD is a temporary wave of electrical activity that spreads in the outer layer of the brain, the cortex. CSD can also directly affect the visual cortex, which contributes to the development of auras associated with migraine. This wave is thought to be caused by the excessive buildup of glutamate, an excitatory neurotransmitter.  CSD is also thought to trigger the release of Calcitonin Gene-Related Peptide (CGRP), a neuropeptide that causes blood vessels to dilate and widen. This leads to the inflammation and pain that occurs during a migraine attack. People with this disease usually take prescription drugs such as sumatriptan and rizatriptan to help reduce the pain. Another common method is using antibodies that target the CGRP receptors and CGRP itself. Further research is necessary to improve our understanding of aural migraines and develop more effective treatments.

References

Robbins, M. S. (2021). Diagnosis and Management of Headache. JAMA, 325(18), 1874. https://doi.org/10.1001/jama.2021.1640

Stovner, L. J., Hagen, K., Linde, M., & Steiner, T. J. (2022). The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. The Journal of Headache and Pain, 23(1). https://doi.org/10.1186/s10194-022-01402-2

Mayo Clinic . (2023, July 7). Migraine - Symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/migraine-headache/symptoms-causes/syc-20360201

Migraine and Cardiovascular Disease: Key Points. (n.d.). American College of Cardiology. Retrieved February 19, 2024, from https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2023/08/15/14/43/migraine-and-cardiovascular-disease

Migraine a “risk factor” for cardiovascular disease. (2018, February 1). Www.medicalnewstoday.com. https://www.medicalnewstoday.com/articles/320783#Cardiovascular-risk-heightened-by-migraine

Lauritzen, M. (1994). Pathophysiology of the migraine aura. Brain, 117(1), 199–210. https://doi.org/10.1093/brain/117.1.199

Charles, A., & Brennan, K. (2009). Cortical Spreading Depression—New Insights and Persistent Questions. Cephalalgia, 29(10), 1115–1124. https://doi.org/10.1111/j.1468-2982.2009.01983.x

Mathew, A. A., & Panonnummal, R. (2022). Cortical spreading depression: culprits and mechanisms. Experimental Brain Research. https://doi.org/10.1007/s00221-022-06307-9

Russo, A. F. (2015). Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine. Annual Review of Pharmacology and Toxicology, 55(1), 533–552. https://doi.org/10.1146/annurev-pharmtox-010814-124701

ElHawary, H., Barone, N., Baradaran, A., & Janis, J. E. (2021). Efficacy and Safety of Migraine Surgery. Annals of Surgery, Publish Ahead of Print. https://doi.org/10.1097/sla.0000000000005057

May, A., & Goadsby, P. J. (1999). The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 19(2), 115–127. https://doi.org/10.1097/00004647-199902000-00001

Ashina, M., Hansen, J. M., Do, T. P., Melo-Carrillo, A., Burstein, R., & Moskowitz, M. A. (2019). Migraine and the trigeminovascular system—40 years and counting. The Lancet Neurology, 18(8), 795–804. https://doi.org/10.1016/s1474-4422(19)30185-1

Salahi, M., Parsa, S., Delaram Nourmohammadi, Zahra Razmkhah, Salimi, O., Rahmani, M., Saeid Zivary, Monireh Askarzadeh, Mohammad Amin Tapak, Vaezi, A., Hamidreza Sadeghsalehi, Shirin Yaghoobpoor, Mehran Mottahedi, Setareh Garousi, & Niloofar Deravi. (2022). Immunologic aspects of migraine: A review of literature. Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.944791

Russell, F. A., King, R., Smillie, S.-J. ., Kodji, X., & Brain, S. D. (2014). Calcitonin Gene-Related Peptide: Physiology and Pathophysiology. Physiological Reviews, 94(4), 1099–1142. https://doi.org/10.1152/physrev.00034.2013

Labastida-Ramírez, A., Caronna, E., Cédric Gollion, Stanyer, E. C., Austėja Dapkutė, Braniste, D., Hoda Naghshineh, L. Meksa, Nino Chkhitunidze, Tamari Gudadze, Pozo‐Rosich, P., Burstein, R., & Hoffmann, J. (2023). Mode and site of action of therapies targeting CGRP signaling. Journal of Headache and Pain, 24(1). https://doi.org/10.1186/s10194-023-01644-8

Håkan Ashina, Henrik Winther Schytz, & Messoud Ashina. (2018). CGRP in Human Models of Migraine. Handbook of Experimental Pharmacology, 109–120. https://doi.org/10.1007/164_2018_128

Alpuente A, Gallardo Vj, Asskour L, Caronna E, Torres-Ferrus M, & Pozo-Rosich P. (2020). Salivary CGRP as diagnostic and migraine attack phase monitor biomarker: CGRP (in)dependent attacks. MedRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/2020.11.18.20233841

Kuburas, A., & Russo, A. F. (2023). Shared and independent roles of CGRP and PACAP in migraine pathophysiology. The Journal of Headache and Pain, 24(1). https://doi.org/10.1186/s10194-023-01569-2

May, A., & Goadsby, P. J. (2001). Substance P receptor antagonists in the therapy of migraine. Expert Opinion on Investigational Drugs, 10(4), 673–678. https://doi.org/10.1517/13543784.10.4.673

Kursun, O., Yemisci, M., van den Maagdenberg, A. M. J. M., & Karatas, H. (2021). Migraine and neuroinflammation: the inflammasome perspective. The Journal of Headache and Pain, 22(1). https://doi.org/10.1186/s10194-021-01271-1

Ramachandran, R. (2018). Neurogenic inflammation and its role in migraine. Seminars in Immunopathology, 40(3), 301–314. https://doi.org/10.1007/s00281-018-0676-y

Branco, A. C. C. C., Yoshikawa, F. S. Y., Pietrobon, A. J., & Sato, M. N. (2018). Role of Histamine in Modulating the Immune Response and Inflammation. Mediators of Inflammation, 2018, 1–10. https://doi.org/10.1155/2018/9524075

Tfelt-Hansen, P. (2009). History of migraine with aura and cortical spreading depression from 1941 and onwards. Cephalalgia, 30(7), 780–792. https://doi.org/10.1111/j.1468-2982.2009.02015.x

Lauritzen, M., Dreier, J. P., Fabricius, M., Hartings, J. A., Graf, R., & Strong, A. J. (2010). Clinical Relevance of Cortical Spreading Depression in Neurological Disorders: Migraine, Malignant Stroke, Subarachnoid and Intracranial Hemorrhage, and Traumatic Brain Injury. Journal of Cerebral Blood Flow & Metabolism, 31(1), 17–35. https://doi.org/10.1038/jcbfm.2010.191

Pi, C., Tang, W., Li, Z., Liu, Y., Qi, J., Dai, W., Wang, T., Yang, C., & Yu, S. (2022). Cortical pain induced by optogenetic cortical spreading depression: from whole brain activity mapping. Molecular Brain, 15(1). https://doi.org/10.1186/s13041-022-00985-w

Hadjikhani, N., Sanchez del Rio, M., Wu, O., Schwartz, D., Bakker, D., Fischl, B., Kwong, K. K., Cutrer, F. M., Rosen, B. R., Tootell, R. B. H., Sorensen, A. G., & Moskowitz, M. A. (2001). Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proceedings of the National Academy of Sciences, 98(8), 4687–4692. https://doi.org/10.1073/pnas.071582498

Kentar, M., Mann, M., Sahm, F., Olivares-Rivera, A., Sanchez-Porras, R., Zerelles, R., Sakowitz, O. W., Unterberg, A. W., & Santos, E. (2020). Detection of spreading depolarizations in a middle cerebral artery occlusion model in swine. Acta Neurochirurgica, 162(3), 581–592. https://doi.org/10.1007/s00701-019-04132-8

Borsook, D., Maleki, N., & Burstein, R. (2015, January 1). Chapter 42 - Migraine (M. J. Zigmond, L. P. Rowland, & J. T. Coyle, Eds.). ScienceDirect; Academic Press. https://www.sciencedirect.com/science/article/abs/pii/B9780123982704000422?via%3Dihub

Frederiksen, S. D., Haanes, K. A., Warfvinge, K., & Edvinsson, L. (2017). Perivascular neurotransmitters: Regulation of cerebral blood flow and role in primary headaches. Journal of Cerebral Blood Flow & Metabolism, 39(4), 610–632. https://doi.org/10.1177/0271678x17747188

25 Migraine Treatments, Preventative Meds & Abortive Drugs. (n.d.). WebMD. https://www.webmd.com/migraines-headaches/migraine-treatments

Mayo Clinic. (2019). Migraine - Diagnosis and treatment - Mayo Clinic. Mayoclinic.org; Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/migraine-headache/diagnosis-treatment/drc-20360207

Agostoni, E. C., Barbanti, P., Calabresi, P., Colombo, B., Cortelli, P., Frediani, F., Geppetti, P., Grazzi, L., Leone, M., Martelletti, P., Pini, L. A., Prudenzano, M. P., Sarchielli, P., Tedeschi, G., & Russo, A. (2019). Current and emerging evidence-based treatment options in chronic migraine: a narrative review. The Journal of Headache and Pain, 20(1). https://doi.org/10.1186/s10194-019-1038-4

Cho, S., & Kim, B.-K. (2023). Update of Gepants in the Treatment of Chronic Migraine. Current Pain and Headache Reports. https://doi.org/10.1007/s11916-023-01167-6

Bolt, A. (n.d.). Nerve Decompression Surgery for Migraine. WebMD. https://www.webmd.com/migraines-headaches/migraine-nerve-release-surgery

Migraine Surgery: What You Need to Know. (2022, February 28). Healthline. https://www.healthline.com/health/migraine/migraine-surgery/

Downloads

Posted

2024-04-20